TAMBE Japan Post-Marketing Surveillance

Launched by W.L.GORE & ASSOCIATES ·

Keywords

ClinConnect Summary

This clinical trial is studying a medical device called the TAMBE system, which is designed to treat a serious condition where a part of the large artery near the heart, called the thoracoabdominal aorta, becomes weakened and bulges out (known as an aneurysm). The goal of this study is to see how safe and effective this device is when used in real-world medical practice after it has already been approved for use.

The trial is open to all adults who have this type of aneurysm, although specific age details are not yet provided. Participants can expect to receive treatment using the TAMBE device, which includes a special graft that helps reinforce the weakened artery and restore normal blood flow. Since this study is still in the early stages and not yet recruiting, people interested should stay in touch with their doctors to learn more when the trial begins. This study is important because it helps doctors understand how well the TAMBE device works and how safe it is when used outside of tightly controlled research settings.

Gender

ALL

Eligibility criteria